Gossamer Bio, Inc. (GOSS)
NASDAQ: GOSS · Real-Time Price · USD
0.522
-0.058 (-10.03%)
At close: Mar 5, 2026, 4:00 PM EST
0.510
-0.012 (-2.26%)
After-hours: Mar 5, 2026, 4:50 PM EST
Gossamer Bio Stock Forecast
GOSS's stock price has decreased by -53.73% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 8 analysts with 12-month price forecasts for Gossamer Bio stock have an average target of 5.54, with a low estimate of 0.30 and a high estimate of 11. The average target predicts an increase of 961.71% from the current stock price of 0.52.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Gossamer Bio stock from 9 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 3 | 3 | 3 | 4 | 2 | 3 |
| Hold | 0 | 0 | 0 | 0 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 7 | 8 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Oppenheimer | Oppenheimer | Buy Maintains $12 → $3 | Buy | Maintains | $12 → $3 | +474.93% | Mar 5, 2026 |
| Wedbush | Wedbush | Buy → Hold Downgrades $6 → $1 | Buy → Hold | Downgrades | $6 → $1 | +91.64% | Feb 24, 2026 |
| Barclays | Barclays | Buy → Sell Downgrades $9 → $0.3 | Buy → Sell | Downgrades | $9 → $0.3 | -42.51% | Feb 24, 2026 |
| Leerink Partners | Leerink Partners | Buy → Hold Downgrades $6 → $1 | Buy → Hold | Downgrades | $6 → $1 | +91.64% | Feb 24, 2026 |
| Barclays | Barclays | Buy Initiates $9 | Buy | Initiates | $9 | +1,624.80% | Jan 28, 2026 |
Financial Forecast
Revenue This Year
43.04M
from 114.70M
Decreased by -62.48%
Revenue Next Year
32.83M
from 43.04M
Decreased by -23.72%
EPS This Year
-0.75
from -0.25
EPS Next Year
-0.54
from -0.75
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 51.6M | 93.8M | ||||
| Avg | 43.0M | 32.8M | ||||
| Low | 34.0M | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -55.0% | 117.9% | ||||
| Avg | -62.5% | -23.7% | ||||
| Low | -70.4% | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -0.68 | -0.29 | ||||
| Avg | -0.75 | -0.54 | ||||
| Low | -0.78 | -0.94 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.